The 6 most recent market catalysts affecting $LOVE, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 11, 2026
Corporate Catalyst
Bearish
Impact 85
Lovesac Analysts Cut Their Forecasts After Q2 Earnings
Lovesac's Q2 earnings presented a mixed picture: while adjusted EPS slightly beat expectations, sales missed, and the company's forward sales guidance was notably lowered for both …
Sep 10, 2026
Corporate Catalyst
Bearish
Impact 85
Lovesac Shares Slide as Softer Sales Forecast Offsets Tariff-Fueled Profit Gain
Lovesac's Q2 fiscal 2027 earnings report presented a dichotomy: strong GAAP profitability, boosted significantly by tariff refunds, contrasted with a sales miss and a downward revi…
Sep 10, 2026
Corporate Catalyst
Bearish
Impact 75
Lovesac shares are trading lower after the company reported mixed Q2 financial results.
The headline indicates a direct negative impact on Lovesac (LOVE) due to its Q2 financial results. 'Mixed' results often imply that while some metrics might have met expectations, …
Sep 10, 2026
Corporate Catalyst
Bullish
Impact 92
Lovesac Q2 Adj. EPS $(0.35) Beats $(0.36) Estimate, Sales $161.245M Miss $165.485M Estimate
Lovesac's Q2 earnings report presents a mixed bag for investors. While the company successfully beat analyst estimates for adjusted EPS, demonstrating improved cost management or o…
Sep 10, 2026
Corporate Catalyst
Neutral
Impact 95
Lovesac Sees Q3 GAAP EPS $0.62-$0.83 vs $(0.53) Est; Sees Sales $140.000M-$150.000M vs $159.835M Est
Lovesac has provided preliminary Q3 guidance, projecting GAAP EPS of $0.62-$0.83, which is significantly above the analyst estimate of $(0.53). However, the company also guided Q3 …
Jul 15, 2026
Corporate Catalyst
Bullish
Impact 92
Cannara Biotech Q3 EPS $0.05 Beats $0.03 Estimate, Sales $31.828M Beat $31.233M Estimate
Cannara Biotech (LOVE) delivered a substantial beat on both Q3 EPS and sales estimates, with EPS exceeding by 66.67% and sales by 1.90%. This indicates strong financial performance…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.